Implementation Manager (12-15 month Maternity Cover) at HeartFlow

United Kingdom

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Medical Technology, Healthcare, CardiologyIndustries

Requirements

Knowledge and experience with CCTA (Cardiac CT Angiography) is required
Cardiology, imaging, or related product experience
Possible radiographer background with strong technical/clinical exposure
Proven project management experience (certification a plus)
Highly well-organized and able to manage multiple concurrent projects
Positive, energetic personality; comfortable in front of groups/customers
Strong customer-focus and adaptability
Excellent problem-solving skills, especially under pressure
Knowledge of hospital operations and technology implementation
Strong verbal and written communication skills

Responsibilities

Lead HeartFlow’s implementation process for integrating our technology into new customer accounts
Manage implementation projects for new products or features
Provide end-user and commercial team training on HeartFlow products and CT data requirements, according to training plans
Deliver clinically relevant and technical information in response to customer and commercial inquiries
Document and track customer feedback, training, complaints, and resolutions in HeartFlow’s CRM system
Collaborate with internal stakeholders to redesign and improve customer support processes
Support commercial growth by helping to design solutions, data insights, and tools
Respond to escalated technical issues from customers or the commercial team

Skills

Project Management

Implementation Management

Medical Technology

Healthcare IT

Stakeholder Management

AI Healthcare

Coronary Imaging

FFRCT Analysis

CCTA

Regulatory Compliance

HeartFlow

Non-invasive cardiac testing for heart disease

About HeartFlow

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries, including the United States, the United Kingdom, Japan, and Canada. Unlike many competitors, HeartFlow focuses on providing a comprehensive suite of analyses that enhance treatment planning. The goal of HeartFlow is to improve cardiovascular care by making it safer and more efficient for both patients and healthcare providers.

Redwood City, CaliforniaHeadquarters

2010Year Founded

$858.5MTotal Funding

SERIES_FCompany Stage

HealthcareIndustries

501-1,000Employees

Benefits

Remote Work Options

Stock Options

401(k) Company Match

Risks

Emerging AI-driven competitors could threaten HeartFlow's market share.

Algorithmic bias in AI models could lead to inaccurate diagnoses.

Integration into healthcare systems may face resistance due to complexity and cost.

Differentiation

HeartFlow offers the only combined anatomy, physiology, and plaque analysis for heart disease.

HeartFlow's non-invasive FFRCT Analysis is FDA-cleared and widely available globally.

HeartFlow's AI-driven technology provides personalized 3D heart models for precise diagnostics.

Upsides

HeartFlow closed a $215 million Series F funding round in April 2023.

The global non-invasive cardiac imaging market is projected to grow significantly.

HeartFlow's technology aligns with the trend towards value-based care in healthcare.

Land your dream remote job 3x faster with AI

Try Jobo Free